STOCK TITAN

REGENXBIO Inc. (RGNX) Net Income by Year

RGNX

REGENXBIO Inc. reported a net loss of $193.9M in fiscal year 2025. This represents an increase of 14.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $196.4M net loss. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters REGENXBIO Inc. has filed alongside them.

FY2025 annual
Net Income -$193.9M
YoY +14.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RGNX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income-$196.4M-$193.9M+14.6%-$227.1M+13.8%-$263.5M+6.0%-$280.3M-319.3%$127.8M+214.9%-$111.3M-17.4%-$94.7M-194.8%$99.9M+236.6%-$73.2M-16.2%-$63.0M-176.0%-$22.8M-469.8%-$4.0M+25.7%-$5.4M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

RGNX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$22.7M+132.0%-$90.1M-1580.4%-$67.1M-31.2%-$61.9M-3.9%-$70.9M-33.7%$6.1M+109.6%-$51.2M+18.6%-$59.6M+3.7%-$53.0M+26.5%-$63.3M+5.0%-$62.9M-4.9%-$61.9M+18.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More REGENXBIO Inc. financials

Frequently Asked Questions

What was REGENXBIO Inc.'s net income in fiscal year 2025?

REGENXBIO Inc. reported a net loss of $193.9M in fiscal year 2025.

How fast is REGENXBIO Inc.'s net income growing?

REGENXBIO Inc. (RGNX) net income rose by 14.6% year over year, from -$227.1M to -$193.9M in fiscal year 2025.

What is REGENXBIO Inc.'s net income over the last twelve months?

REGENXBIO Inc. (RGNX) reported a $196.4M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, REGENXBIO Inc. (RGNX) net income went from -$5.4M in fiscal year 2013 to -$193.9M in fiscal year 2025.

REGENXBIO Inc. (RGNX) reported $22.7M in net income in Q2 2026. This represents an increase of 132.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what REGENXBIO Inc. (RGNX) reported on that line in every period on record.